EP1076090A3 - ESTs und deren kodierte Humanproteine - Google Patents

ESTs und deren kodierte Humanproteine

Info

Publication number
EP1076090A3
EP1076090A3 EP00202699.5A EP00202699A EP1076090A3 EP 1076090 A3 EP1076090 A3 EP 1076090A3 EP 00202699 A EP00202699 A EP 00202699A EP 1076090 A3 EP1076090 A3 EP 1076090A3
Authority
EP
European Patent Office
Prior art keywords
ests
human proteins
encoded human
encoded
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00202699.5A
Other languages
English (en)
French (fr)
Other versions
EP1104808A1 (de
EP1076090A2 (de
Inventor
Jean-Baptiste Dumas Milne Edwards
Severin Jobert
Jean-Yves Giordano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Priority to EP04078018A priority Critical patent/EP1541683A1/de
Publication of EP1076090A2 publication Critical patent/EP1076090A2/de
Publication of EP1076090A3 publication Critical patent/EP1076090A3/de
Publication of EP1104808A1 publication Critical patent/EP1104808A1/de
Ceased legal-status Critical Current

Links

EP00202699A 1999-08-05 2000-07-27 ESTs und deren kodierte Humanproteine Ceased EP1104808A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04078018A EP1541683A1 (de) 1999-08-05 2000-07-27 ESTs und deren kodierte Humanproteine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14749999P 1999-08-05 1999-08-05
US147499P 1999-08-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP04078018A Division EP1541683A1 (de) 1999-08-05 2000-07-27 ESTs und deren kodierte Humanproteine

Publications (3)

Publication Number Publication Date
EP1076090A2 EP1076090A2 (de) 2001-02-14
EP1076090A3 true EP1076090A3 (de) 2001-03-21
EP1104808A1 EP1104808A1 (de) 2001-06-06

Family

ID=22521809

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00202699A Ceased EP1104808A1 (de) 1999-08-05 2000-07-27 ESTs und deren kodierte Humanproteine

Country Status (4)

Country Link
US (2) US6639063B1 (de)
EP (1) EP1104808A1 (de)
JP (1) JP2002010789A (de)
CA (1) CA2311201A1 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE69934580T2 (de) * 1998-04-29 2007-10-04 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Mit cd40 und traf interagierende proteine
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
GB9820002D0 (en) * 1998-09-14 1998-11-04 Smithkline Beecham Biolog Novel compounds
US20030009013A1 (en) * 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU764092B2 (en) * 1999-03-23 2003-08-07 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7408047B1 (en) * 1999-09-07 2008-08-05 Amgen Inc. Fibroblast growth factor-like polypeptides
US7459540B1 (en) * 1999-09-07 2008-12-02 Amgen Inc. Fibroblast growth factor-like polypeptides
US6875854B1 (en) * 1999-11-18 2005-04-05 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
US6716626B1 (en) * 1999-11-18 2004-04-06 Chiron Corporation Human FGF-21 nucleic acids
EP1301600A2 (de) * 2000-01-28 2003-04-16 Lexicon Genetics Incorporated Humane enzyme und polynukleotide, die dafür kodieren
ATE490979T1 (de) * 2000-02-14 2010-12-15 Takeshi Iwatsubo Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
US20020107190A1 (en) * 2000-02-25 2002-08-08 Chung Ching Ming Novel genes and expression products therefrom
WO2001083705A1 (en) * 2000-04-27 2001-11-08 Kyowa Hakko Kogyo Co., Ltd. Myocardial cell proliferation-associated genes
WO2001093902A2 (en) * 2000-06-07 2001-12-13 Biosynexus Incorporated Immunostimulatory rna/dna hybrid molecules
US7355023B2 (en) * 2000-06-29 2008-04-08 Duke University Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
JP2002142765A (ja) * 2000-07-14 2002-05-21 Tosoh Corp 新規ゲノム解析法
US7335732B2 (en) * 2000-08-01 2008-02-26 Genentech, Inc. PRO9799 polypeptides
US7442765B2 (en) * 2000-08-24 2008-10-28 Genentech, Inc. Secreted transmembrane polypeptides and nucleic acids encoding the same
DE60135482D1 (de) * 2000-11-09 2008-10-02 Cenix Bioscience Gmbh Eukaryontische zellteilungsgene und deren verwendung in der diagnostik sowie in der behandlung von proliferativen erkrankungen
US7220844B2 (en) * 2000-12-14 2007-05-22 Wisconsin Alumni Research Foundation Liver tumor marker sequences
WO2002060466A2 (en) * 2001-02-02 2002-08-08 Genset S.A. Gssp3 polynucleotides and polypeptides and uses thereof
US7601825B2 (en) * 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US20120076789A1 (en) * 2001-02-08 2012-03-29 Agensys, Inc. Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
US6924358B2 (en) * 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
WO2002083921A2 (en) * 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20030022205A1 (en) * 2001-05-09 2003-01-30 Millennium Pharmaceuticals, Inc. 98359, a sodium channel beta 4 subunit, and uses therefor
US7157558B2 (en) * 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
US20030104385A1 (en) * 2001-08-02 2003-06-05 Evans Glen A. Nucleic acids and encoded polypeptides associated with bipolar disorder
GB0118995D0 (en) 2001-08-03 2001-09-26 Univ Wales Medicine Detection of mutations in nucleic acids
IL160531A0 (en) * 2001-09-07 2004-07-25 Genfit Compositions and methods for aa4rp assay
JP2005504534A (ja) 2001-09-19 2005-02-17 アメリカ合衆国政府 トランスダクチン−１及びトランスダクチン−２並びに遺伝性聴覚障害への適用
US20060088828A1 (en) * 2002-01-23 2006-04-27 Harris Peter C Polycystic kidney disease nucleic acids and proteins
AT500282A3 (de) * 2002-03-28 2006-06-15 Jsw Res Forschungslabor Gmbh Neurotrophe und neuroprotektive peptide
MXPA04009959A (es) * 2002-04-12 2004-12-13 Schering Corp Ligandos del receptor acoplado a la proteina g y metodos.
US7038030B2 (en) * 2002-04-16 2006-05-02 University Of South Florida BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof
WO2003091436A1 (fr) * 2002-04-26 2003-11-06 Fujisawa Pharmaceutical Co., Ltd. Nouvelle proteine 35kd
PL375202A1 (en) * 2002-05-07 2005-11-28 Immunex Corporation Cytokine polypeptides
WO2004004649A2 (en) * 2002-07-08 2004-01-15 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CN1681834A (zh) * 2002-08-14 2005-10-12 株式会社Lg生命科学 肝癌相关的基因家族
TW200413539A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Genes and polypeptides relating to prostate cancers
GB0308241D0 (en) * 2003-04-10 2003-05-14 Univ Wales Medicine Screening methods and sequences relating thereto
EP1626986A2 (de) * 2003-05-16 2006-02-22 Genova Ltd. Sezernierte polypeptide, die mit herz-kreislauf-erkrankungen in verbindung stehen
US20050069918A1 (en) * 2003-05-29 2005-03-31 Francois Claret JAB1 as a prognostic marker and a therapeutic target for human cancer
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7485430B2 (en) 2004-04-15 2009-02-03 The Curators Of The University Of Missouri Methods and compositions for evaluation of fertility
EP2369350B1 (de) * 2004-04-20 2014-08-20 SphingoTec GmbH Verwendung von Vorstufen von Tachykininen und/oder ihren Fragmenten in der medizinischen Diagnostik
US7892733B1 (en) 2004-04-22 2011-02-22 Amgen Inc. Response element regions
JP4635001B2 (ja) 2004-04-28 2011-02-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ｔｈ１細胞の検出方法
US7672950B2 (en) * 2004-05-04 2010-03-02 The Boston Consulting Group, Inc. Method and apparatus for selecting, analyzing, and visualizing related database records as a network
ES2363156T3 (es) * 2004-05-13 2011-07-22 B.R.A.H.M.S Gmbh Uso de precursores de encefalinas y/o sus fragmentos en diagnosis médica.
ATE456666T1 (de) * 2004-05-26 2010-02-15 Anima Cell Metrology Verfahren zur auswertung von ribonukleotidsequenzen
US20060008875A1 (en) * 2004-07-06 2006-01-12 Universitair Medisch Centrum Rotterdam Novel TFIIH subunit
US7670776B1 (en) 2004-07-22 2010-03-02 Myriad Genetics, Inc. MYH gene variants and use thereof
US7563571B1 (en) 2004-07-22 2009-07-21 Myriad Genetics, Inc. MYH gene variants and use thereof
GB0417887D0 (en) * 2004-08-11 2004-09-15 Ares Trading Sa Protein
US20110177079A1 (en) * 2004-09-08 2011-07-21 Ludwig Institute For Cancer Research Cancer-testis antigens
US20070172843A1 (en) * 2005-09-12 2007-07-26 Conrad Susan E MEK interacting protein 1 as diagnostic and therapeutic target for breast cancer treatment and prevention
WO2008054534A2 (en) 2006-05-11 2008-05-08 Quark Pharmaceuticals, Inc. Screening systems utilizing rtp801
WO2007141796A2 (en) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Therapeutic uses of inhibitors of rtp801l
US8751479B2 (en) * 2007-09-07 2014-06-10 Brand Affinity Technologies, Inc. Search and storage engine having variable indexing for information associations
WO2009047760A2 (en) * 2007-10-09 2009-04-16 Anima Cell Metrology, Inc. Systems and methods for measuring translation activity in viable cells
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
US20110119785A1 (en) * 2008-03-13 2011-05-19 Ceres, Inc. Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions
US8034770B2 (en) 2008-06-04 2011-10-11 Amgen Inc. FGF21 polypeptides comprising two or more mutations
CA2739615C (en) 2008-10-10 2017-12-05 Amgen Inc. Fgf21 mutants comprising polyethylene glycol and uses thereof
WO2010099472A2 (en) 2009-02-27 2010-09-02 The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services Spanx-b polypeptides and their use
WO2010129503A1 (en) * 2009-05-05 2010-11-11 Amgen Inc. Fgf21 mutants and uses thereof
WO2010129600A2 (en) 2009-05-05 2010-11-11 Amgen Inc. Fgf21 mutants and uses thereof
MX2011013903A (es) * 2009-06-17 2012-05-08 Amgen Inc Polipeptidos quimericos y usos de los mismos.
US9034576B2 (en) 2009-09-24 2015-05-19 Anima Cell Metrology Inc. Systems and methods for measuring translation of target proteins in cells
EP2679234A3 (de) * 2009-12-02 2014-04-23 Amgen Inc. Bindeproteine zur Bindung an humanem FGFR1C, humanem beta-Klotho sowie humanem FGFR1C als auch humanem beta-Klotho
UA109888C2 (uk) * 2009-12-07 2015-10-26 ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
US8492333B2 (en) 2010-02-22 2013-07-23 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Peptides and methods for inducing cell death
CA2796055A1 (en) 2010-04-15 2011-10-20 Amgen Inc. Human fgf receptor and .beta.-klotho binding proteins
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
EP2571513B1 (de) * 2010-05-17 2016-09-07 aTyr Pharma, Inc. Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von leucyl-trna-synthetasen
JP2012100557A (ja) * 2010-11-08 2012-05-31 Institute Of Physical & Chemical Research 新規遺伝子およびｆｏｎｇ遺伝子座の一塩基多型に基づく骨粗鬆症の検査方法
EP2780449B1 (de) 2011-11-18 2018-04-11 Novozymes, Inc. Polypeptide mit beta-glucosidase-aktivität, beta-xylosidase-aktivität oder beta-glucosidase- und beta-xylosidase-aktivität sowie dafür kodierende polynukleotide
US8715995B2 (en) * 2011-11-18 2014-05-06 Novozymes A/S Polypeptides having beta-glucosidase activity and beta-xylosidase activity and polynucleotides encoding same
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
CN104411338A (zh) 2012-04-02 2015-03-11 现代治疗公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
AU2013374345A1 (en) 2013-01-17 2015-08-06 Moderna Therapeutics, Inc. Signal-sensor polynucleotides for the alteration of cellular phenotypes
EP2968391A1 (de) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Langlebige polynukleotidmoleküle
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
CA2917348A1 (en) 2013-07-11 2015-01-15 Moderna Therapeutics, Inc. Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
EP3041934A1 (de) 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Chimäre polynukleotide
WO2015034925A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
EP3052521A1 (de) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynukleotide zur codierung von low-density-lipoprotein-rezeptor
US20170204152A1 (en) 2014-07-16 2017-07-20 Moderna Therapeutics, Inc. Chimeric polynucleotides
EP3171895A1 (de) 2014-07-23 2017-05-31 Modernatx, Inc. Modifizierte polynukleotide zur herstellung von intrabodys
US10696974B2 (en) 2014-12-23 2020-06-30 Ilya Pharma Ab Methods for wound healing
EP3274476B1 (de) * 2015-03-25 2023-06-07 The General Hospital Corporation Digitaler analyse zirkulierender tumorzellen in blutproben
GB201507030D0 (en) * 2015-04-24 2015-06-10 Immatics Biotechnologies Gmbh Immunotherapy against lung cancers, in particular NSCLC
TWI782434B (zh) 2015-08-28 2022-11-01 德商英麥提克生物技術股份有限公司 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架
US10335471B2 (en) 2015-08-28 2019-07-02 Immatics Biotechnologies Gmbh Method for treating cancer with activated T cells
GB201515321D0 (en) 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
EP3985127A1 (de) 2016-10-27 2022-04-20 The General Hospital Corporation Digitale analyse von blutproben zur bestimmung der wirksamkeit von krebstherapien für bestimmte krebserkrankungen
TW202019457A (zh) 2018-08-02 2020-06-01 瑞士商諾華公司 新的肌肉因子及其用途
CN109706165A (zh) * 2018-12-24 2019-05-03 杭州师范大学 可在大肠杆菌中实现重组子筛选的乳酸菌分泌型载体及其构建方法、应用
CN110064045B (zh) * 2019-05-15 2022-12-23 苏州大学 微肽cip2a-bp在治疗癌症中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733762B1 (fr) 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
WO1998022575A2 (en) * 1996-11-22 1998-05-28 Human Genome Sciences, Inc. Nucleotide sequence of escherichia coli pathogenicity islands
US6110899A (en) * 1997-02-28 2000-08-29 Smithkline Beecham Corporation LICC of Streptococcus pneumoniae
JP2002506627A (ja) 1998-03-19 2002-03-05 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９５個のヒト分泌タンパク質
CA2319089A1 (en) 1998-04-09 1999-10-21 Genset S.A. 5' ests and encoded human proteins
JP2002543771A (ja) * 1999-04-09 2002-12-24 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ６２個のヒト分泌タンパク質

Similar Documents

Publication Publication Date Title
EP1076090A3 (de) ESTs und deren kodierte Humanproteine
EP1076090A2 (de) ESTs und deren kodierte Humanproteine
AU715620C (en) Therapeutic methods and uses
AU1608201A (en) Human zven proteins
AU4480697A (en) Human nm23-like protein
AU3574900A (en) Human cervical cancer 1 protooncogene and protein encoded therein
AU2067501A (en) Human oxidoreductase proteins
AU1626101A (en) Human transcriptomes
AU5475199A (en) Human chordin-related proteins and polynucleotides encoding them
AU9017598A (en) Human frezzled-like protein
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4992099A (en) Human presenilin-associated protein
AU2136401A (en) P450rai-2 and related proteins
AU8747098A (en) Human galectin-9-like proteins and cdnas encoding these proteins
AU2001245367A1 (en) Human transporter genes and proteins encoded thereby
AU2593199A (en) Human smn-like protein
AU4151597A (en) Human dbi/acbp-like protein
AU7600598A (en) Human metaxin protein
AU5760200A (en) Human genes and proteins encoded thereby
AU7259898A (en) Human smt-3 like protein
AU2076701A (en) Novel human transporter protein and polynucleotides encoding the same
AU5309500A (en) Novel human genes and proteins encoded thereby
AU2002233265A1 (en) Human caplain proteins and polynucleotides coding therefor
AU2002345407A1 (en) Human cervical cancer 5 protooncogene and protein encoded therein
AU2001274923A1 (en) Novel human thrombospondin-like proteins and polynucleotides encoding the same

Legal Events

Date Code Title Description
AK Designated contracting states:

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Extension of the european patent to

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20011128

AKX Payment of designation fees

Free format text: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report

Effective date: 20030710

RAP1 Applicant reassignment (correction)

Owner name: GENSET

RAP1 Applicant reassignment (correction)

Owner name: SERONO GENETICS INSTITUTE S.A.

RAP1 Applicant reassignment (correction)

Owner name: SERONO GENETICS INSTITUTE S.A.

18R Refused

Effective date: 20050127